tiprankstipranks
Dexcom (DXCM)
NASDAQ:DXCM

Dexcom (DXCM) Technical Analysis

3,162 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Dexcom’s (DXCM) Moving Averages Convergence Divergence (MACD) indicator is -0.92, suggesting Dexcom is a Sell.
Dexcom’s (DXCM) 20-Day exponential moving average is 129.19, while Dexcom’s (DXCM) share price is $127.64, making it a Sell.
Dexcom’s (DXCM) 50-Day exponential moving average is 129.76, while Dexcom’s (DXCM) share price is $127.64, making it a Sell.

Dexcom (DXCM) Pivot Points

May 29, 2024, 11:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
121.49
123.02
125.19
126.72
128.89
130.42
132.59
Fibonacci
123.02
124.43
125.30
126.72
128.13
129.00
130.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dexcom (DXCM) Moving Averages

May 29, 2024, 11:29 PM
Period
Simple
Exponential
MA5
128.34Sell
128.01Sell
MA10
129.14Sell
128.52Sell
MA20
128.35Sell
129.19Sell
MA50
132.73Sell
129.76Sell
MA100
128.35Sell
127.26Buy
MA200
115.25Buy
120.91Buy
Dexcom’s (DXCM) 10-Day exponential moving average is 128.52, while Dexcom’s (DXCM) share price is $127.64, making it a Sell.
Dexcom’s (DXCM) 100-Day exponential moving average is 127.26, while Dexcom’s (DXCM) share price is $127.64, making it a Buy.
Dexcom’s (DXCM) stock price is $127.64 and Dexcom’s (DXCM) 50-day simple moving average is 132.73, creating a Sell signal.
Dexcom’s (DXCM) stock price is $127.64 and Dexcom’s (DXCM) 100-day simple moving average is 128.35, creating a Sell signal.
Dexcom’s (DXCM) stock price is $127.64 and Dexcom’s (DXCM) 200-day simple moving average is 115.25, creating a Buy signal.

Dexcom (DXCM) Technical Indicators

May 29, 2024, 11:29 PM
Name
Value
Implied Action
RSI (14)
45.08
Neutral
STOCH (9,6)
30.86
Neutral
STOCHRSI (14)
31.63
Neutral
MACD (12,26)
-0.92
Sell
ADX (14)
20.89
Neutral
Williams %R
-60.92
Buy
CCI (14)
-61.72
Neutral
ATR (14)
3.43
-
Ultimate Oscillator
45.27
Neutral
ROC
-2.09
Sell
Dexcom’s (DXCM) Relative Strength Index (RSI) is 45.08, creating a Neutral signal.
Dexcom’s (DXCM) Trend Strength Indicator (ADX) is 20.89, creating a Neutral signal.
Dexcom’s (DXCM) Commodity Channel Index (CCI) is -61.72, creating a Neutral signal.
Dexcom’s (DXCM) Price Rate of Change (ROC) is -2.09, creating a Sell signal.

FAQ

Is DXCM a Buy, Hold, or Sell?
Based on DXCM’s technical indicators, DXCM is a Sell.
    What is DXCM’s RSI (14)?
    DXCM’s RSI (14) is 45.08, which suggests DXCM is a Neutral.
      What is DXCM’s MACD?
      DXCM’s MACD is -0.92, which suggests DXCM is a Sell.
        What is DXCM’s 5-day moving average?
        DXCM’s 5-day moving average is 128.34, which suggests DXCM is a Sell.
          What is DXCM’s 20-day moving average?
          DXCM 20-day moving average is 128.35, which suggests DXCM is a Sell.
            What is DXCM’s 50-day moving average?
            DXCM’s 50-day moving average is 132.73, which suggests DXCM is a Sell.
              What is DXCM’s 200-day moving average?
              DXCM’s 200-day moving average is 115.25, which suggests DXCM is a Buy.
                What is DXCM’s Williams % R (14)?
                DXCM’s Williams % R (14) is -60.92, which suggests DXCM is a Buy.
                  What is DXCM’s CCI (14)?
                  DXCM’s CCI (14) is -61.72, which suggests DXCM is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis